e-learning
resources
Barcelona 2010
Monday, 20.09.2010
The role of biomarkers in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Electronic nose distinguishes lung cancer from smoking and nonsmoking controls
A. G. Dent, R. V. Bowman, P. V. Zimmerman, I. A. Yang, K. M. Fong (Brisbane, Australia)
Source:
Annual Congress 2010 - The role of biomarkers in lung cancer
Session:
The role of biomarkers in lung cancer
Session type:
Oral Presentation
Number:
1948
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. G. Dent, R. V. Bowman, P. V. Zimmerman, I. A. Yang, K. M. Fong (Brisbane, Australia). Electronic nose distinguishes lung cancer from smoking and nonsmoking controls. Eur Respir J 2010; 36: Suppl. 54, 1948
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers
Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer
Year: 2010
An electronic nose in the discrimination of patients with lung cancer and controls
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012
Breath biomarkers of lung cancer and other diseases
Source: Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease
Year: 2010
Comparative characteristics of lung cancer in smokers and nonsmokers
Source: Eur Respir J 2001; 18: Suppl. 33, 115s
Year: 2001
IPF and lung cancer: what are the links?
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Year: 2009
Metabolomic profiles in lung cancer subjects and healthy controls. Influence of smoking tobacco exposure
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Does knowledge of public smokers about lung cancer differ than non-smokers?
Source: Eur Respir J 2005; 26: Suppl. 49, 158s
Year: 2005
An electronic nose distinguishes the exhaled breath condensates of AATD patients and healthy controls
Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs
Year: 2008
Different cytological alterations of bronchial mucosa in 178 smoking and non-smoking patients, suffering from COPD: the importance of endobronchial brushing
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009
Relationship between COPD, smoking status and lung cancer histology
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Genes expressions subtraction of non-cancerous tissue from smokers and non-smokers with adenocarcinoma of lung, may be used as markers for early detection of lung cancer in smoker
Source: Eur Respir J 2006; 28: Suppl. 50, 812s
Year: 2006
Epidemiology of lung cancer and mesothelioma
Source: Eur Respir Mon; 2009: 44: 349–391
Year: 2009
Molecular signatures of exposure and subtype in lung cancer tissue from uranium miners
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010
Community spirometry screening in asymptomatic smokers and ex-smokers in the diagnosis of COPD and smoking cessation
Source: Annual Congress 2010 - Diagnostic and therapeutic strategies in primary care
Year: 2010
Characteristics of nonsmoker lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 781s
Year: 2006
Effect of 4 years of CT screening for lung cancer on smoking habits
Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Year: 2010
Improvements in lung cancer surgery
Source: Annual Congress 2011 - Surgery for lung cancer: pre-operative evaluation and results
Year: 2011
An electronic nose distinguishes the exhaled breath condensates of patient groups with COPD, alpha-1-antitrypsin deficiency and healthy controls
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept